Fetal exposure to canakinumab: a report of three pregnancies
dc.authorid | kucuksahin, orhan/0000-0003-4530-2304 | |
dc.authorid | Eyupoglu, Sahin/0000-0002-8009-6262 | |
dc.authorid | Yayla, Mucteba Enes/0000-0002-5998-6703 | |
dc.authorid | Ilgen, Ufuk/0000-0001-6443-6426 | |
dc.authorwosid | ilgen, ufuk/R-8761-2017 | |
dc.authorwosid | kucuksahin, orhan/GZA-3287-2022 | |
dc.authorwosid | eyupoglu, sahin/AEC-2529-2022 | |
dc.authorwosid | Yayla, Mucteba Enes/N-2948-2017 | |
dc.contributor.author | Ilgen, Ufuk | |
dc.contributor.author | Eyupoglu, Sahin | |
dc.contributor.author | Yayla, Mucteba Enes | |
dc.contributor.author | Kucuksahin, Orhan | |
dc.date.accessioned | 2024-06-12T11:17:33Z | |
dc.date.available | 2024-06-12T11:17:33Z | |
dc.date.issued | 2022 | |
dc.department | Trakya Üniversitesi | en_US |
dc.description.abstract | [Abstract Not Available] | en_US |
dc.identifier.doi | 10.1007/s10067-022-06060-y | |
dc.identifier.endpage | 1263 | en_US |
dc.identifier.issn | 0770-3198 | |
dc.identifier.issn | 1434-9949 | |
dc.identifier.issue | 4 | en_US |
dc.identifier.pmid | 35018583 | en_US |
dc.identifier.scopus | 2-s2.0-85122732336 | en_US |
dc.identifier.scopusquality | Q2 | en_US |
dc.identifier.startpage | 1261 | en_US |
dc.identifier.uri | https://doi.org/10.1007/s10067-022-06060-y | |
dc.identifier.uri | https://hdl.handle.net/20.500.14551/24755 | |
dc.identifier.volume | 41 | en_US |
dc.identifier.wos | WOS:000741211700001 | en_US |
dc.identifier.wosquality | Q3 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Springer London Ltd | en_US |
dc.relation.ispartof | Clinical Rheumatology | en_US |
dc.relation.publicationcategory | Diğer | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Anakinra Use | en_US |
dc.title | Fetal exposure to canakinumab: a report of three pregnancies | en_US |
dc.type | Letter | en_US |